Curetis Announces Participation in Several Investor and Industry Conferences in Q2-2016

(PresseBox) ( Amsterdam, the Netherlands and Holzgerlingen, Germany, )
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced its participation in several major industry conferences in the second quarter of 2016. The respective investor presentations will be made available on the company's website.


26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 9 - 12, 2016, in Amsterdam, The Netherlands: scientific meeting

Morgan Stanley Panel discussion and Meeting on Infectious Disease Diagnostics, April 14, 2016 in New York, NY, USA


Bio€quity Europe 2016, May 10-11, 2016 in Copenhagen, Denmark: management presentation

35th Annual Conference of the Austrian Society for Hygiene, Microbiology and Prevention (ÖGHMP), May 30-June 2nd in Zell am See, Austria: scientific meeting


Swiss MedLab, June 13-16, Berne, Switzerland: scientific meeting

For further information, please visit

This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.

The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This press release includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will", or "should", and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis' actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

According to §§ 190 ff. German Reorganization Act (UmwG) and by way of enrolment in the commercial register at district court Stuttgart on March 15, 2016 Curetis plc (AG) changed its legal form into Curetis Ltd. (GmbH).
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to